Sovelis LLC

Sovelis LLC was founded to develop and commercialize high throughput, innovative assay platforms for detecting abnormal heart rhythm (arrhythmia) conditions. 


A major public health concern in recent years has been increasing reports of adverse cardiac events, including sudden cardiac death (heart attack), that have been associated with the use of non-cardiac drugs.  To address this public health concern, Sovelis LLC is leveraging innovative developments in cellular assays with greater than 40 years experience understanding the cellular and molecular causes of cardiac arrhythmias. 

Contact Us Today!

To schedule an appointment or find out more about the services we offer, please call 617 297-2863 or send us an email.


Or use our contact form.

News & Events

Sovelis LLC receives NIH SBIR grant

Sovelis to attend NHLBI Regional Innovation Conference-Midwest in Columbus, Ohio on March 4, 2015.

Read all news and events.

Get Social with Us!

Print Print | Sitemap
© Sovelis LLC